|

TIL Clinical Trials

2 actively recruiting trials

Pipeline

Phase 2: 1Phase 1/2: 1

Top Sponsors

  • Tongji Hospital1
  • Sheba Medical Center1

Indications

  • Cancer2
  • Malignant Melanoma Stage IV1
  • Recurrence Tumor1
  • Metastatic Cancer1
  • Solid Tumor1

Other2 trials

Adoptive Cell Therapy Following a Non-myeloablative, Lymphodepleting Induction Regimen in Metastatic Melanoma Patients
Phase 2
Immunotherapy for the Treatment of Advanced Solid Tumor
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.